Cargando…
Striatal dopaminergic lesions contributed to the disease severity in progressive supranuclear palsy
BACKGROUND: Reduced dopamine transporter (DAT) binding in the striatum has been reported in patients with progressive supranuclear palsy (PSP). However, the relationship between striatal dopaminergic lesions and the disease severity of PSP remains to be explored. OBJECTIVE: To investigate the contri...
Autores principales: | Chen, Ming-Jia, Lu, Jia-Ying, Li, Xin-Yi, Jiao, Fang-Yang, Zuo, Chuan-Tao, Wang, Jian, Liu, Feng-Tao, Yang, Yu-Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454812/ https://www.ncbi.nlm.nih.gov/pubmed/36092815 http://dx.doi.org/10.3389/fnagi.2022.998255 |
Ejemplares similares
-
Clinical features of progressive supranuclear palsy
por: Wen, Yafei, et al.
Publicado: (2023) -
Waiting impulsivity in progressive supranuclear palsy-Richardson’s syndrome
por: Ahn, Jong Hyeon, et al.
Publicado: (2023) -
Actin-binding protein filamin-A drives tau aggregation and contributes to progressive supranuclear palsy pathology
por: Tsujikawa, Koyo, et al.
Publicado: (2022) -
[(18)F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy
por: Brendel, Matthias, et al.
Publicado: (2018) -
(18)F-Florzolotau PET imaging captures the distribution patterns and regional vulnerability of tau pathology in progressive supranuclear palsy
por: Liu, Feng-Tao, et al.
Publicado: (2023)